The European Vaccine Action Plan 2015–2020 defined HBV control through immunisation as one of its major strategic goals [10]. Furthermore, to reach the goal of eliminating viral hepatitis as a public health threat in Europe by 2030, the action plan for the health sector response to viral hep...
Social differentiation of vaccine hesitancy among French parents and the mediating role of trust and commitment to health: a nationwide cross-sectional study Vaccine, 36 (50) (2018), pp. 7666-7673 View PDFView articleGoogle Scholar 41 L. Moyroud, S. Hustache, L. Goirand, M. Hauzanneau,...
Chapter 4: Hepatitis B. In: Manual for the Surveillance of Vaccine-Preventable Diseases. Centers for Disease Control and Prevention. Published May 31, 2018. Accessed October 22, 2020. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt04-hepb.html 19. Chou R, Blazina I, Bougatsos ...
afflicts more than 250 million people. With nearly one million deaths per year, the resulting chronic hepatitis B (CHB) represents one of the most deadly diseases, especially in Africa and the Western Pacific region1. While an effective prophylactic vaccine is available, current therapies ...
approximately half of them are motivated and willing to go for hepatitis B screening and vaccination simply due to recommendation by a health worker. Only a third of the respondents had a very high likelihood of taking their child for up taking HBV vaccine as a part of scheduled routine immuni...
However, 16.7% of the respondents agreed that HBV vaccine was safe, protects against HBV infection, and poses no harm to the unborn baby. This was similar among respondents in Wa Municipality and Lawra District. Table 5 Expectant mothers’ knowledge of mother-to-child transmission of HBV Full...
Hepatitis C virus infection (HCV) is a communicable disease of increasing global importance with 1.75 million new infections and 400,000 related deaths annually. Until recently, treatment options have had low uptake and most infected people remain untrea
Virus-like particles (VLPs), composed of the small hepatitis B virus surface antigen (HBsAgS), are the antigenic components of the hepatitis B virus (HBV) vaccine and represent the backbones for a chimeric anti-malaria vaccine and various vaccine candidates. Biological vectors have to face pre...